HK1130060A1 - Novel crystal of substituted phenylalkanoic acid and production process - Google Patents

Novel crystal of substituted phenylalkanoic acid and production process

Info

Publication number
HK1130060A1
HK1130060A1 HK09110023.1A HK09110023A HK1130060A1 HK 1130060 A1 HK1130060 A1 HK 1130060A1 HK 09110023 A HK09110023 A HK 09110023A HK 1130060 A1 HK1130060 A1 HK 1130060A1
Authority
HK
Hong Kong
Prior art keywords
production process
novel crystal
phenylalkanoic acid
substituted phenylalkanoic
substituted
Prior art date
Application number
HK09110023.1A
Other languages
English (en)
Inventor
Yuichi Arimoto
Naoyuki Ishii
Motoshi Shoda
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Publication of HK1130060A1 publication Critical patent/HK1130060A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK09110023.1A 2006-07-20 2009-10-28 Novel crystal of substituted phenylalkanoic acid and production process HK1130060A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006197637 2006-07-20
PCT/JP2007/063896 WO2008010448A1 (fr) 2006-07-20 2007-07-12 Nouveaux cristaux d'acide phénylalcanoïque substitué et leur procédé de production

Publications (1)

Publication Number Publication Date
HK1130060A1 true HK1130060A1 (en) 2009-12-18

Family

ID=38956781

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09110023.1A HK1130060A1 (en) 2006-07-20 2009-10-28 Novel crystal of substituted phenylalkanoic acid and production process
HK13100299.3A HK1173722A1 (en) 2006-07-20 2013-01-09 Crystal of substituted phenylalkanoic acid and production process

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK13100299.3A HK1173722A1 (en) 2006-07-20 2013-01-09 Crystal of substituted phenylalkanoic acid and production process

Country Status (13)

Country Link
US (4) US7560478B2 (xx)
EP (2) EP2045244B1 (xx)
JP (2) JP5137834B2 (xx)
KR (3) KR101322116B1 (xx)
CN (2) CN101490012B (xx)
AU (2) AU2007274477B2 (xx)
CA (3) CA2773177C (xx)
DK (1) DK2045244T3 (xx)
ES (1) ES2402782T3 (xx)
HK (2) HK1130060A1 (xx)
MX (1) MX2009000448A (xx)
PT (1) PT2045244E (xx)
WO (1) WO2008010448A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009205073B2 (en) * 2008-01-18 2012-04-12 Asahi Kasei Pharma Corporation Stable pharmaceutical composition
EP2272832A4 (en) * 2008-04-28 2011-09-07 Asahi Kasei Pharma Corp PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0495025A (ja) 1990-08-08 1992-03-27 Asahi Chem Ind Co Ltd アルドースリダクターゼ阻害剤
JPH0495049A (ja) 1990-08-08 1992-03-27 Asahi Chem Ind Co Ltd ビフェニル‐５，５’‐ビス‐アルカン酸誘導体、その製造法およびその用途
WO1999019291A1 (fr) 1997-10-14 1999-04-22 Asahi Kasei Kogyo Kabushiki Kaisha Derives de biphenyl-5-acide alcanoique et leurs applications
IL154718A0 (en) 2000-09-07 2003-10-31 Kaneka Corp Methods for crystallization of hydroxycarboxylic acids
WO2003026572A2 (en) * 2001-09-26 2003-04-03 Merck & Co., Inc. Crystalline forms of ertapenem sodium
ITRM20020016A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
US6867320B2 (en) * 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
PT1477472E (pt) * 2002-02-21 2009-03-17 Asahi Kasei Pharma Corp Derivado de ácido fenilalcanóico substituído e sua utilização
KR20060079190A (ko) * 2003-08-14 2006-07-05 아사히 가세이 파마 가부시키가이샤 치환 아릴알칸산 유도체 및 그의 용도
ES2296520B1 (es) * 2005-05-18 2009-04-01 Chemagis Ltd. Procesos mejorados de preparacion de forma a de telmisartan de alta pureza, adecuada para composiciones farmaceuticas.

Also Published As

Publication number Publication date
HK1173722A1 (en) 2013-05-24
KR20130108487A (ko) 2013-10-02
AU2007274477B2 (en) 2010-11-25
CN101490012B (zh) 2012-07-18
JP5550696B2 (ja) 2014-07-16
JPWO2008010448A1 (ja) 2009-12-17
WO2008010448A1 (fr) 2008-01-24
US7754752B2 (en) 2010-07-13
CA2659471C (en) 2012-06-12
EP2620431A1 (en) 2013-07-31
CA2773177C (en) 2013-09-24
CA2659471A1 (en) 2008-01-24
US20080070967A1 (en) 2008-03-20
US7560478B2 (en) 2009-07-14
JP2013028638A (ja) 2013-02-07
CA2820931A1 (en) 2008-01-24
KR101322116B1 (ko) 2013-10-25
CA2820931C (en) 2015-08-18
MX2009000448A (es) 2009-01-27
CN102690234A (zh) 2012-09-26
US20110021593A1 (en) 2011-01-27
US20100234440A1 (en) 2010-09-16
US20090312386A1 (en) 2009-12-17
AU2007274477A1 (en) 2008-01-24
AU2011200408B2 (en) 2011-05-26
CA2773177A1 (en) 2008-01-24
CN102690234B (zh) 2014-12-24
CN101490012A (zh) 2009-07-22
EP2045244B1 (en) 2013-04-03
JP5137834B2 (ja) 2013-02-06
DK2045244T3 (da) 2013-04-15
EP2045244A1 (en) 2009-04-08
AU2011200408A1 (en) 2011-02-24
KR20080104063A (ko) 2008-11-28
ES2402782T8 (es) 2013-06-10
ES2402782T3 (es) 2013-05-08
EP2045244A4 (en) 2010-09-08
PT2045244E (pt) 2013-04-15
US7838546B2 (en) 2010-11-23
KR20120084790A (ko) 2012-07-30
US7935720B2 (en) 2011-05-03
KR101440255B1 (ko) 2014-09-17

Similar Documents

Publication Publication Date Title
HK1137486A1 (en) Microbiological production of 3-hydroxyisobutyric acid
EP2100957A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
ZA200709028B (en) Process for the production of acetic acid
EP2088153A4 (en) GLUTATHIONIC CRYSTAL AND METHOD FOR THE PRODUCTION THEREOF
PL1784378T3 (pl) Sposób wytwarzania surowego kwasu tereftalowego
EP2138518A4 (en) Polymer-stabilized liquid crystalline composition, liquid crystal display and method for producing a liquid crystal display
EP2003209A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
EP2083083A4 (en) PROCESS FOR PRODUCING L-AMINO ACID
EP2070684A4 (en) METHOD FOR PRODUCING A POLYMILIC ACID FILM
EP2093210A4 (en) PROCESS FOR THE PREPARATION OF TEREPHTHALIC ACID
EP2100872A4 (en) PROCESS FOR PRODUCTION OF ACRYLIC ACID, APPARATUS FOR PRODUCTION OF ACRYLIC ACID, AND COMPOSITION FOR THE PRODUCTION OF ACRYLIC ACID
EP2067770A4 (en) PROCESS FOR THE PREPARATION OF SULPHONIC ACID ESTERS
PT1989165T (pt) Processo para produção de ácido carboxílico
EP1900821A4 (en) PROCESS FOR THE PRODUCTION OF L-FORM AMINO ACID
EP2080808A4 (en) PROCESS FOR PRODUCING L-AMINO ACID
EP1914220A4 (en) PROCESS FOR THE PREPARATION OF 2-HYDROXYESTERS
EP2133356A4 (en) METHOD FOR PRODUCING A PHOSPHORUS-CONTAINING KETOSIC ACID
EP1990416A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
IL194938A0 (en) Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof
PT2079843T (pt) Processo para a produção de biogás
EP2088136A4 (en) PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
EP2093211A4 (en) PROCESS FOR PRODUCTION OF ISOPHTHALIC ACID
ZA200905851B (en) Method for the production of acrylic acid
IL196642A0 (en) Process for production of optically active aminophosphinylbutanoic acid
ZA200708141B (en) Process for production of sulphuric acid

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170712